Matthew Meyer
About Matthew Meyer
Matthew Meyer is the Senior Director and Head of Discovery Pharmacology and In Vivo Biology at Bristol-Myers Squibb in Cambridge, Massachusetts, with over 20 years of experience in pharmacology and in vivo biology.
Company
Matthew Meyer is currently working at Bristol-Myers Squibb in Cambridge, Massachusetts. He joined the company in February 2019 and holds the title of Senior Director and Head, Discovery Pharmacology and In Vivo Biology.
Title
Matthew Meyer serves as the Senior Director and Head of Discovery Pharmacology and In Vivo Biology at Bristol-Myers Squibb. His role involves overseeing discovery pharmacology and in vivo biology efforts to advance pharmaceutical research and development.
Education and Expertise
Matthew Meyer completed his PhD at Cornell University from 2000 to 2005. Prior to that, he obtained an MS from Kansas State University, studying there from 1998 to 2000. He also earned a BS from Kansas State University, where he studied from 1994 to 1998. With over 20 years of experience in pharmacology and in vivo biology, his educational background and professional expertise position him as a leader in the field.
Background
Matthew Meyer's career began with an internship at Elanco in Indianapolis, Indiana, where he gained early industry experience. He then served as a Postdoctoral Fellow at the National Cancer Institute from 2005 to 2010, focusing on cancer research. He further developed his expertise in oncology pharmacology during his tenure at Novartis from 2010 to 2019, before joining Bristol-Myers Squibb.
Achievements
Matthew Meyer has had a long and varied career in pharmacology and in vivo biology. His tenure at the National Cancer Institute included a focus on cancer research, which laid the groundwork for his subsequent work in oncology pharmacology at Novartis. His current role at Bristol-Myers Squibb highlights his progression to a leadership position overseeing critical areas of pharmaceutical research.